Maurits K. Konings
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maurits K. Konings has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Roland A. Snijder
Department of Medical Physics, Medical Centre Haaglanden, Burgemeester Banninglaan 1, Den Haag, Zuid-Holland, 2501 CK, NETHERLANDS
3 shared publications Annemoon M. Timmerman
Dept. of Medical Technology and Clinical Physics , University Medical Center Utrecht , Utrecht , Netherlands
2 shared publications- Annemoon M. Timmerman
Department of Medical Technology and Clinical Physics, University Medical Center Utrecht, Room AZU - C.01.230, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands
2 shared publications - Frank E. Rademakers
Division of Cardiovascular Imaging and Dynamics, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium
2 shared publications - Henk G Goovaerts
Dept. of Medical Technology, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publications - Pieter Afm Doevendans
Netherlands Heart Institute (NLHI), Utrecht, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 18 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 26131
New method for neuromodulation against pain using minimally invasive electrodes outside the epidural space
Chronic pain is cumbersome, difficult to treat and a growing and costly problem in modern medical care. Spinal cord stimulation (SCS) has proven to be an effective technique for pain mitigation in many cases. Despite being generally safe, the procedure carries increased risks for patients on anti-coagulant medication due to the catheter placement in the epidural space inside the spinal canal. Since these medical conditions are mainly prevalent in the elderly, among which chronic pain is also particularly common and problematic, a large group of patients are nowadays potentially excluded from the benefits of the spinal cord stimulation. Furthermore, the occurrence of SCS catheter dislocation adds to these challenges. In this paper, we present a novel multi-electrode implant platform (SNAP, safe neuromodulation against pain) that does not need entry into the vulnerable epidural space. This technique aims to extend pain mitigation benefits to patients currently ineligible for traditional spinal cord implants. Moreover, the implant is rigidly locked onto the vertebral bone, has the potential to reduce the risk of migration. As a first step, the feasibility of stimulating the spinal cord electrically using only the SNAP electrodes located outside the epidural space, has been tested using finite element method (FEM) computer simulations, assessing the implant's ability to selectively stimulate the dorsal column fibers without the undesired stimulation of the muscles in the back. Furthermore, in-vitro experiments have been performed to test the feasibility of the wireless energy transfer method. The FEM simulations conducted in this paper show that a low-frequency current of 6.30 mA and 1.26 mA from the primary and the secondary SNAP electrodes, respectively, gives rise to a selective stimulation of the dorsal column fibers. The in-vitro experiments confirm the feasibility of sufficient wireless energy transfer. We presented a first proof of concept for a new method of safe neuromodulation against pain, focussing on the electric aspects of the method. Our preliminary results suggest that this new approach may potentially overcome some limitations associated with standard SCS.
- 18 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 26131
Open AccessNew method for neuromodulation against pain using minimally invasive electrodes outside the epidural space
Chronic pain is cumbersome, difficult to treat and a growing and costly problem in modern medical care. Spinal cord stimulation (SCS) has proven to be an effective technique for pain mitigation in many cases. Despite being generally safe, the procedure carries increased risks for patients on anti-coagulant medication due to the catheter placement in the epidural space inside the spinal canal. Since these medical conditions are mainly prevalent in the elderly, among which chronic pain is also particularly common and problematic, a large group of patients are nowadays potentially excluded from the benefits of the spinal cord stimulation. Furthermore, the occurrence of SCS catheter dislocation adds to these challenges. In this paper, we present a novel multi-electrode implant platform (SNAP, safe neuromodulation against pain) that does not need entry into the vulnerable epidural space. This technique aims to extend pain mitigation benefits to patients currently ineligible for traditional spinal cord implants. Moreover, the implant is rigidly locked onto the vertebral bone, has the potential to reduce the risk of migration. As a first step, the feasibility of stimulating the spinal cord electrically using only the SNAP electrodes located outside the epidural space, has been tested using finite element method (FEM) computer simulations, assessing the implant's ability to selectively stimulate the dorsal column fibers without the undesired stimulation of the muscles in the back. Furthermore, in-vitro experiments have been performed to test the feasibility of the wireless energy transfer method. The FEM simulations conducted in this paper show that a low-frequency current of 6.30 mA and 1.26 mA from the primary and the secondary SNAP electrodes, respectively, gives rise to a selective stimulation of the dorsal column fibers. The in-vitro experiments confirm the feasibility of sufficient wireless energy transfer. We presented a first proof of concept for a new method of safe neuromodulation against pain, focussing on the electric aspects of the method. Our preliminary results suggest that this new approach may potentially overcome some limitations associated with standard SCS.
- Open Access
- 1 January 2024
- Published by IOP Publishing in Physiological Measurement
- Vol. 45 (1) , 01NT01
The hemodynamic cardiac profiler volume-time curves and related parameters: an MRI validation study
Background. The hemodynamic cardiac profiler (HCP) is a new, non-invasive, operator-independent screening tool that uses six independent electrode pairs on the frontal thoracic skin, and a low-intensity, patient-safe, high-frequency applied alternating current to measure ventricular volume dynamics during the cardiac cycle for producing ventricular volume-time curves (VTCs). Objective. To validate VTCs from HCP against VTCs from MRI in healthy volunteers. Approach. Left- and right-ventricular VTCs were obtained by HCP and MRI in six healthy participants in supine position. Since HCP is not compatible with MRI, HCP measurements were performed within 20 min before and immediately after MRI, without intermittent fluid intake or release by participants. Intraclass correlation coefficients (ICCs) were calculated to validate HCP-VTC against MRI-VTC and to assess repeatability of HCP measurements before and after MRI. Bland–Altman plots were used to assess agreement between relevant HCP- and MRI-VTC-derived parameters. Precision of HCP’s measurement of VTC-derived parameters was determined for each study participant by calculating the coefficients of variation and repeatability coefficients. Main results. Left- and right-ventricular VTC ICCs between HCP and MRI were >0.8 for all study participants, indicating excellent agreement between HCP-VTCs and MRI-VTCs. Mean (range) ICC of HCP right-ventricular VTC versus MRI right-ventricular VTC was 0.94 (0.88–0.99) and seemed to be slightly higher than the mean ICC of HCP left-ventricular VTC versus MRI-VTC (0.91 (0.80–0.96)). The repeatability coefficient for HCP’s measurement of systolic time (tSys) was 45.0 ms at a mean value of 282.9 ± 26.3 ms. Repeatability of biventricular HCP-VTCs was excellent (ICC 0.96 (0.907–0.995)). Significance. Ventricular volume dynamics measured by HCP-VTCs show excellent agreement with VTCs measured by MRI. Since abnormal tSys is a sign of numerous cardiac diseases, the HCP may potentially be used as a diagnostic screening tool.
- 1 January 2024
- Published by IOP Publishing in Physiological Measurement
- Vol. 45 (1) , 01NT01
Open AccessThe hemodynamic cardiac profiler volume-time curves and related parameters: an MRI validation study
Background. The hemodynamic cardiac profiler (HCP) is a new, non-invasive, operator-independent screening tool that uses six independent electrode pairs on the frontal thoracic skin, and a low-intensity, patient-safe, high-frequency applied alternating current to measure ventricular volume dynamics during the cardiac cycle for producing ventricular volume-time curves (VTCs). Objective. To validate VTCs from HCP against VTCs from MRI in healthy volunteers. Approach. Left- and right-ventricular VTCs were obtained by HCP and MRI in six healthy participants in supine position. Since HCP is not compatible with MRI, HCP measurements were performed within 20 min before and immediately after MRI, without intermittent fluid intake or release by participants. Intraclass correlation coefficients (ICCs) were calculated to validate HCP-VTC against MRI-VTC and to assess repeatability of HCP measurements before and after MRI. Bland–Altman plots were used to assess agreement between relevant HCP- and MRI-VTC-derived parameters. Precision of HCP’s measurement of VTC-derived parameters was determined for each study participant by calculating the coefficients of variation and repeatability coefficients. Main results. Left- and right-ventricular VTC ICCs between HCP and MRI were >0.8 for all study participants, indicating excellent agreement between HCP-VTCs and MRI-VTCs. Mean (range) ICC of HCP right-ventricular VTC versus MRI right-ventricular VTC was 0.94 (0.88–0.99) and seemed to be slightly higher than the mean ICC of HCP left-ventricular VTC versus MRI-VTC (0.91 (0.80–0.96)). The repeatability coefficient for HCP’s measurement of systolic time (tSys) was 45.0 ms at a mean value of 282.9 ± 26.3 ms. Repeatability of biventricular HCP-VTCs was excellent (ICC 0.96 (0.907–0.995)). Significance. Ventricular volume dynamics measured by HCP-VTCs show excellent agreement with VTCs measured by MRI. Since abnormal tSys is a sign of numerous cardiac diseases, the HCP may potentially be used as a diagnostic screening tool.
- Open Access
- 27 January 2023
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 25 (4) , 1121-1128
Bedside visualisation tool for prediction of deviation from intended dosage in multi-infusion therapy
Background: In multi-infusion therapy, multiple infusion pumps are connected to one single vascular access point. Interaction between pressure changes from different pumps may result in temporary dosing errors, which can be very harmful to the patient. It is known that these dosing errors occur. However, clinicians tend to find it hard to estimate the order of magnitude of these errors. Methods: This research uses an existing mathematical model to create a bedside prediction tool that is able to provide clinicians with the dosing errors that will occur after flow rate changes in multi-infusion therapy. A panel of clinicians, consisting of both nurses and doctors, was formed, and, in order to assess the level of knowledge about dosing errors in multi-infusion, the panel was presented with four medication schedules in which a syringe exchange or change in flow rate took place. The panel was asked to predict the resulting dosing errors. Results: A prediction tool was developed that describes a two pump multi-infusion system and predicts dosing errors resulting from changing the flow rate at one pump. 44% of the panel members wrongly predicted the impact of changing the set flow of liquid A on the flow of liquid B that reaches the patient. Nobody was able to correctly predict the dosing deviation if a very small catheter was used. After the prediction tool was shown, the clinicians indicated they had a improved understanding of what deviations to expect and that the tool would be useful in understanding multi-infusion dosing errors. Conclusions: Using the predictive tool to visualise the deviations from the set flow rate is an effective method to allow clinicians to gain insight in dosing errors in multi-infusion therapy. This knowledge can be used to better anticipate future dosing errors in clinical situations.
- 27 January 2023
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 25 (4) , 1121-1128
Open AccessBedside visualisation tool for prediction of deviation from intended dosage in multi-infusion therapy
Background: In multi-infusion therapy, multiple infusion pumps are connected to one single vascular access point. Interaction between pressure changes from different pumps may result in temporary dosing errors, which can be very harmful to the patient. It is known that these dosing errors occur. However, clinicians tend to find it hard to estimate the order of magnitude of these errors. Methods: This research uses an existing mathematical model to create a bedside prediction tool that is able to provide clinicians with the dosing errors that will occur after flow rate changes in multi-infusion therapy. A panel of clinicians, consisting of both nurses and doctors, was formed, and, in order to assess the level of knowledge about dosing errors in multi-infusion, the panel was presented with four medication schedules in which a syringe exchange or change in flow rate took place. The panel was asked to predict the resulting dosing errors. Results: A prediction tool was developed that describes a two pump multi-infusion system and predicts dosing errors resulting from changing the flow rate at one pump. 44% of the panel members wrongly predicted the impact of changing the set flow of liquid A on the flow of liquid B that reaches the patient. Nobody was able to correctly predict the dosing deviation if a very small catheter was used. After the prediction tool was shown, the clinicians indicated they had a improved understanding of what deviations to expect and that the tool would be useful in understanding multi-infusion dosing errors. Conclusions: Using the predictive tool to visualise the deviations from the set flow rate is an effective method to allow clinicians to gain insight in dosing errors in multi-infusion therapy. This knowledge can be used to better anticipate future dosing errors in clinical situations.
- Open Access
- 16 December 2022
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 68 (1) , 109-116
Unexpected dosing errors due to air bubbles in infusion lines with and without air filters
The effect of the presence of an air bubble, inside an infusion line, on the time (Tnew) needed for a new medication to reach the patient after a syringe exchange was studied in this paper. If an air bubble escapes through an air filter, then a sudden drop in pressure occurs, causing a relaxation of the compressible part of the syringe, followed by a gradual restoration of the flow rate in the line. We modeled this phenomenon mathematically and measured it experimentally in vitro. In an example with a pump flow rate of 5 mL/h and an air bubble of 1 cm length inside an infusion line (diameter 1 mm) with an air filter, both theory and experiment yield an additional increase of at least 600% in delay time if a naive estimate (based on the size of the bubble alone) is replaced by a more realistic estimate incorporating compressibility. Furthermore, we show that an air bubble in a line without air filter may increase Tnew by a factor 2, depending on the initial position of the air bubble. We conclude that an air bubble in an infusion line causes delays that may not be expected by health care professionals.
- 16 December 2022
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 68 (1) , 109-116
Open AccessUnexpected dosing errors due to air bubbles in infusion lines with and without air filters
The effect of the presence of an air bubble, inside an infusion line, on the time (Tnew) needed for a new medication to reach the patient after a syringe exchange was studied in this paper. If an air bubble escapes through an air filter, then a sudden drop in pressure occurs, causing a relaxation of the compressible part of the syringe, followed by a gradual restoration of the flow rate in the line. We modeled this phenomenon mathematically and measured it experimentally in vitro. In an example with a pump flow rate of 5 mL/h and an air bubble of 1 cm length inside an infusion line (diameter 1 mm) with an air filter, both theory and experiment yield an additional increase of at least 600% in delay time if a naive estimate (based on the size of the bubble alone) is replaced by a more realistic estimate incorporating compressibility. Furthermore, we show that an air bubble in a line without air filter may increase Tnew by a factor 2, depending on the initial position of the air bubble. We conclude that an air bubble in an infusion line causes delays that may not be expected by health care professionals.
- Open Access
- 16 December 2022
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 68 (1) , 91-96
Effect of non-return valves on the time-of-arrival of new medication in a patient after syringe exchange in an infusion set-up
The presence of a non-return valve in an infusion set-up is expected to affect the time-of-arrival of new medication in a patient after syringe exchange. Using Computational Fluid Dynamics (CFD) we have studied the flow through a typical non-return valve, focusing on two separate effects: (A) the overall delay in the time-of-arrival, and (B) timing effects due to the distortion of the Poiseuille flow profile in the non-return valve. The results show that (A) the additional delay in time-of-arrival of new medication, caused by the non-return valve alone, corresponds to the delay that would be caused by 11.2 cm of extra infusion line instead of the valve, and that (B) the non-Poiseuille flow profile inside the non-return valve gives rise to an extra slow wash-out of the last portion of the remnant fluid of the old medication. We conclude that awareness of these extra delays may be important for clinicians in certain time-critical situations.
- 16 December 2022
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 68 (1) , 91-96
Open AccessEffect of non-return valves on the time-of-arrival of new medication in a patient after syringe exchange in an infusion set-up
The presence of a non-return valve in an infusion set-up is expected to affect the time-of-arrival of new medication in a patient after syringe exchange. Using Computational Fluid Dynamics (CFD) we have studied the flow through a typical non-return valve, focusing on two separate effects: (A) the overall delay in the time-of-arrival, and (B) timing effects due to the distortion of the Poiseuille flow profile in the non-return valve. The results show that (A) the additional delay in time-of-arrival of new medication, caused by the non-return valve alone, corresponds to the delay that would be caused by 11.2 cm of extra infusion line instead of the valve, and that (B) the non-Poiseuille flow profile inside the non-return valve gives rise to an extra slow wash-out of the last portion of the remnant fluid of the old medication. We conclude that awareness of these extra delays may be important for clinicians in certain time-critical situations.
- Open Access
- 20 June 2019
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 18 (1) , 1-13
High-frequency irreversible electroporation for cardiac ablation using an asymmetrical waveform
Irreversible electroporation (IRE) using direct current (DC) is an effective method for the ablation of cardiac tissue. A major drawback of the use of DC-IRE, however, are two problems: requirement of general anesthesia due to severe muscle contractions and the formation of bubbles containing gaseous products from electrolysis. The use of high-frequency alternating current (HF-IRE) is expected to solve both problems, because HF-IRE produces little to no muscle spasms and does not cause electrolysis. In the present study, we introduce a novel asymmetric, high-frequency (aHF) waveform for HF-IRE and present the results of a first, small, animal study to test its efficacy. The data of the experiments suggest that the aHF waveform creates significantly deeper lesions than a symmetric HF waveform of the same energy and frequency (p = 0.003). We therefore conclude that the use of the aHF enhances the feasibility of the HF-IRE method.
- 20 June 2019
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 18 (1) , 1-13
Open AccessHigh-frequency irreversible electroporation for cardiac ablation using an asymmetrical waveform
Irreversible electroporation (IRE) using direct current (DC) is an effective method for the ablation of cardiac tissue. A major drawback of the use of DC-IRE, however, are two problems: requirement of general anesthesia due to severe muscle contractions and the formation of bubbles containing gaseous products from electrolysis. The use of high-frequency alternating current (HF-IRE) is expected to solve both problems, because HF-IRE produces little to no muscle spasms and does not cause electrolysis. In the present study, we introduce a novel asymmetric, high-frequency (aHF) waveform for HF-IRE and present the results of a first, small, animal study to test its efficacy. The data of the experiments suggest that the aHF waveform creates significantly deeper lesions than a symmetric HF waveform of the same energy and frequency (p = 0.003). We therefore conclude that the use of the aHF enhances the feasibility of the HF-IRE method.
- Open Access
- 18 January 2017
- Published by IOP Publishing in Physiological Measurement
- Vol. 38 (2) , 241-258
Non-invasive measurement of volume–time curves in patients with mitral regurgitation and in healthy volunteers, using a new operator-independent screening tool
Left ventricular volume-time curves (VTCs) provide hemodynamic data, and may help clinical decision making. The generation of VTCs using echocardiography, however, is time-consuming and prone to inter-operator variability. In this study, we used a new non-invasive, operator-independent technique, the hemodynamic cardiac profiler (HCP), to generate VTCs. The HCP, which uses a low-intensity, patient-safe, high-frequency applied AC current, and 12 standard ECG electrodes attached on the thorax in a pre-defined pattern, was applied to five young healthy volunteers, five older healthy volunteers, and five patients with severe mitral regurgitation. From the VTCs generated by the HCP, the presence or absence of an isovolumetric contraction phase (ICP) was assessed, as well as the left ventricular ejection time (LVET), time of the pre-ejection period (tPEP), and ratio of the volumes of the early (E) and late (A) diastolic filling (E V/A V ratio), and compared to 2D transthoracic echocardiography (2D TTE) at rest. The reproducibility by two different operators showed good results (RMS = 5.2%). For intra-patient measurement RMS was 2.8%. Both LVET and the E V/A V ratio showed a strong significant correlation between HCP and 2D TTE derived parameters (p < 0.05). For tPEP, the correlation was still weak (p = 0.32). In all five patients with mitral regurgitation, the ICP was absent in the VTC from the HCP, whereas it was present in the 10 healthy volunteers, which is in accordance with pathophysiology. We conclude that the HCP seems to be a method for reproducible VTC generation, and may become a useful early screening tool for cardiac dysfunction in the future.
- 18 January 2017
- Published by IOP Publishing in Physiological Measurement
- Vol. 38 (2) , 241-258
Open AccessNon-invasive measurement of volume–time curves in patients with mitral regurgitation and in healthy volunteers, using a new operator-independent screening tool
Left ventricular volume-time curves (VTCs) provide hemodynamic data, and may help clinical decision making. The generation of VTCs using echocardiography, however, is time-consuming and prone to inter-operator variability. In this study, we used a new non-invasive, operator-independent technique, the hemodynamic cardiac profiler (HCP), to generate VTCs. The HCP, which uses a low-intensity, patient-safe, high-frequency applied AC current, and 12 standard ECG electrodes attached on the thorax in a pre-defined pattern, was applied to five young healthy volunteers, five older healthy volunteers, and five patients with severe mitral regurgitation. From the VTCs generated by the HCP, the presence or absence of an isovolumetric contraction phase (ICP) was assessed, as well as the left ventricular ejection time (LVET), time of the pre-ejection period (tPEP), and ratio of the volumes of the early (E) and late (A) diastolic filling (E V/A V ratio), and compared to 2D transthoracic echocardiography (2D TTE) at rest. The reproducibility by two different operators showed good results (RMS = 5.2%). For intra-patient measurement RMS was 2.8%. Both LVET and the E V/A V ratio showed a strong significant correlation between HCP and 2D TTE derived parameters (p < 0.05). For tPEP, the correlation was still weak (p = 0.32). In all five patients with mitral regurgitation, the ICP was absent in the VTC from the HCP, whereas it was present in the 10 healthy volunteers, which is in accordance with pathophysiology. We conclude that the HCP seems to be a method for reproducible VTC generation, and may become a useful early screening tool for cardiac dysfunction in the future.
- Open Access
- 17 January 2017
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 16 (1) , 1-28
Analytical method for calculation of deviations from intended dosages during multi-infusion
In this paper, a new method is presented that combines mechanical compliance effects with Poiseuille flow and push-out effects (“dead volume”) in one single mathematical framework for calculating dosing errors in multi-infusion set-ups. In contrast to existing numerical methods, our method produces explicit expressions that illustrate the mathematical dependencies of the dosing errors on hardware parameters and pump flow rate settings. Our new approach uses the Z-transform to model the contents of the catheter, and after implementation in Mathematica (Wolfram), explicit expressions are produced automatically. Consistency of the resulting analytical expressions has been examined for limiting cases, and three types of in-vitro measurements have been performed to obtain a first experimental test of the validity of the theoretical results. The relative contribution of various factors affecting the dosing errors, such as the Poiseuille flow profile, resistance and internal volume of the catheter, mechanical compliance of the syringes and the various pump flow rate settings, can now be discerned clearly in the structure of the expressions generated by our method. The in-vitro experiments showed a standard deviation between theory and experiment of 14% for the delay time in the catheter, and of 13% for the time duration of the dosing error bolus. Our method provides insight and predictability in a large range of possible situations involving many variables and dependencies, which is potentially very useful for e.g. the development of a fast, bed-side tool (“calculator”) that provides the clinician with a precise prediction of dosing errors and delay times interactively for many scenario’s. The interactive nature of such a device has now been made feasible by the fact that, using our method, explicit expressions are available for these situations, as opposed to conventional time-consuming numerical simulations.
- 17 January 2017
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 16 (1) , 1-28
Open AccessAnalytical method for calculation of deviations from intended dosages during multi-infusion
In this paper, a new method is presented that combines mechanical compliance effects with Poiseuille flow and push-out effects (“dead volume”) in one single mathematical framework for calculating dosing errors in multi-infusion set-ups. In contrast to existing numerical methods, our method produces explicit expressions that illustrate the mathematical dependencies of the dosing errors on hardware parameters and pump flow rate settings. Our new approach uses the Z-transform to model the contents of the catheter, and after implementation in Mathematica (Wolfram), explicit expressions are produced automatically. Consistency of the resulting analytical expressions has been examined for limiting cases, and three types of in-vitro measurements have been performed to obtain a first experimental test of the validity of the theoretical results. The relative contribution of various factors affecting the dosing errors, such as the Poiseuille flow profile, resistance and internal volume of the catheter, mechanical compliance of the syringes and the various pump flow rate settings, can now be discerned clearly in the structure of the expressions generated by our method. The in-vitro experiments showed a standard deviation between theory and experiment of 14% for the delay time in the catheter, and of 13% for the time duration of the dosing error bolus. Our method provides insight and predictability in a large range of possible situations involving many variables and dependencies, which is potentially very useful for e.g. the development of a fast, bed-side tool (“calculator”) that provides the clinician with a precise prediction of dosing errors and delay times interactively for many scenario’s. The interactive nature of such a device has now been made feasible by the fact that, using our method, explicit expressions are available for these situations, as opposed to conventional time-consuming numerical simulations.
- 1 July 2015
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 16 (4) , 327-332
Correct Positioning of Central Venous Catheters using a New Electric Method
Purpose: In order to find the correct final position of the tip of a central venous catheter, we have developed a new electric method (the Proximity of Cardiac Motion (PCM) method), designed to work in tandem with the existing ECG-based method. Methods: A small, patient-safe, high-frequency current is fed through the catheter (via the saline-filled lumen of the catheter, or a stylet). Simultaneously, the resulting voltage is measured by two electrodes on the frontal thoracic skin. The catheter tip hence functions as a current source inside the vasculature. The cardiac motion produces a variation in the amplitude of the measured voltage in the rhythm of the cardiac cycle, and the strength of this oscillatory variation is proportional to the strength of the incident current field on the heart, which is a rapidly decaying function of the distance between the catheter tip and the cavoatrial junction (CAJ). Hence the strength of this oscillatory variation is a strong indicator for the proximity of the catheter tip with respect to the CAJ. Results: The new method has been tested in an animal model, yielding an average final position of the catheter tip of 2.1 cm above the CAJ, with a maximum deviation of 0.5 cm. Conclusions: We conclude that the new PCM method can be combined with the existing ECG method, and may potentially have significant added value when the ECG method cannot be applied, for example, in patients with atrial fibrillation or a pacemaker.
- 1 July 2015
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 16 (4) , 327-332
Correct Positioning of Central Venous Catheters using a New Electric Method
Purpose: In order to find the correct final position of the tip of a central venous catheter, we have developed a new electric method (the Proximity of Cardiac Motion (PCM) method), designed to work in tandem with the existing ECG-based method. Methods: A small, patient-safe, high-frequency current is fed through the catheter (via the saline-filled lumen of the catheter, or a stylet). Simultaneously, the resulting voltage is measured by two electrodes on the frontal thoracic skin. The catheter tip hence functions as a current source inside the vasculature. The cardiac motion produces a variation in the amplitude of the measured voltage in the rhythm of the cardiac cycle, and the strength of this oscillatory variation is proportional to the strength of the incident current field on the heart, which is a rapidly decaying function of the distance between the catheter tip and the cavoatrial junction (CAJ). Hence the strength of this oscillatory variation is a strong indicator for the proximity of the catheter tip with respect to the CAJ. Results: The new method has been tested in an animal model, yielding an average final position of the catheter tip of 2.1 cm above the CAJ, with a maximum deviation of 0.5 cm. Conclusions: We conclude that the new PCM method can be combined with the existing ECG method, and may potentially have significant added value when the ECG method cannot be applied, for example, in patients with atrial fibrillation or a pacemaker.
- 1 January 2015
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 60 (4) , 365-376
How physical infusion system parameters cause clinically relevant dose deviations after setpoint changes
Multi-infusion therapy, in which multiple pumps are connected to one access point, is frequently used in patient treatments. This practice is known to cause dosing errors following setpoint changes in the drug concentrations that actually enter the patients. Within the Metrology for Drug Delivery Project, we analyzed and quantified the two main physical phenomena leading to these errors: the “push-out” effect and the system mechanical compliance. We compared the dosing errors of a three-pump system with two infusion sets, both with and without anti-reflux valves, using in vitro spectrophotometric experiments. Additionally, computer simulations were used to study the compliance effect separately. We found a start-up time of more than 1 h, and a dosing error following a setpoint increase of another pump for the low flow rate pump, corresponding to 0.5 μg noradrenaline delivered in 8 min. We showed that the dead volume inside the tubes and syringe compliance produce opposite deviations from the setpoint values in the actual drug output concentrations, making the net result hard to predict and often counterintuitive. We conclude that metrology on compliance and push-out effects could be used by infusion device manufacturers to successfully improve drug delivery performance and relevant standards for high-risk multi-infusion applications.
- 1 January 2015
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 60 (4) , 365-376
How physical infusion system parameters cause clinically relevant dose deviations after setpoint changes
Multi-infusion therapy, in which multiple pumps are connected to one access point, is frequently used in patient treatments. This practice is known to cause dosing errors following setpoint changes in the drug concentrations that actually enter the patients. Within the Metrology for Drug Delivery Project, we analyzed and quantified the two main physical phenomena leading to these errors: the “push-out” effect and the system mechanical compliance. We compared the dosing errors of a three-pump system with two infusion sets, both with and without anti-reflux valves, using in vitro spectrophotometric experiments. Additionally, computer simulations were used to study the compliance effect separately. We found a start-up time of more than 1 h, and a dosing error following a setpoint increase of another pump for the low flow rate pump, corresponding to 0.5 μg noradrenaline delivered in 8 min. We showed that the dead volume inside the tubes and syringe compliance produce opposite deviations from the setpoint values in the actual drug output concentrations, making the net result hard to predict and often counterintuitive. We conclude that metrology on compliance and push-out effects could be used by infusion device manufacturers to successfully improve drug delivery performance and relevant standards for high-risk multi-infusion applications.